CBD fruit jellies: Exploring the vast benefits of CBD edibles
Industry-leading CBD experts Dr. Hemp Me detail the exciting benefits of CBD fruit jellies and the range of conditions they can alleviate.
In a world...
Over 450,000 patients used NHS online GP registration in its first year
Over 425,000 NHS patients have used the new online GP registration service. Find out how to register with a GP online.
NHS launches trials to advance wireless technology in healthcare
NHS England has launched trials to help accelerate the development and uptake of wireless technology in healthcare.
As part of the trials, NHS organisations will...
Dr. Hemp Me’s guide to CBD oil in Greece
Dr. Hemp Me explains everything you need to know about the landscape of CBD oil in Greece.
CBD is gaining a lot of attention these...
A journey into the world of CBD oil in Italy
Learn how Dr. Hemp Me has transformed the perception of CBD oil in Italy, setting them apart as a true trailblazer.
In recent years, CBD...
Key link to autism spectrum disorder revealed in new mini-brain study
Mayo Clinic and Yale University scientists have used a mini-brain model to reveal the link to autism spectrum disorder.
Sepsis prevention: The alliance of vaccinations, sanitation, and the vaccine cold chain
Sepsis is a severe bodily reaction to infection, which can cause fever, breathlessness, disorientation, tissue damage, and organ failure, among other symptoms.
While bacterial infections...
AI breast cancer screening is safe and detects 20% more cancers
Lund University research suggests that AI breast cancer screening is a safe alternative to traditional screening, identifies more cancer cases, and is more efficient.
The...
Could a basic income scheme save the NHS tens of billions of pounds?
Health Europa looks at how a basic income scheme could revolutionise NHS funding, potentially saving billions of pounds.
In the tapestry of socio-economic strategies, there...
Zentek and McMaster announce positive results for the aptamer platform
Zentek has announced that its aptamer platform, under global license from McMaster University, has been successfully tested as a therapeutic for SARS-CoV-2 in pre-clinical...
Defence completes first milestone of Orano collaboration agreement
Defence Therapeutics Inc. has announced that it has successfully reached the first milestone established in the Orano collaboration agreement.
The collaboration agreement was entered with...
ADHD diagnoses increase twenty-fold among UK men
News University College London research suggests that ADHD diagnoses have risen dramatically in the UK in the last 20 years, particularly among men.
ADHD, which...
UK and BioNTech SE sign landmark deal for cancer vaccine trials
The UK Government has established a historic agreement with German-based BioNTech SE for cancer vaccine trials.
The groundbreaking deal will improve access to cancer vaccine...
NHS approves sight-saving ranibizumab drug for premature babies
The NHS has approved the use of ranibizumab – a revolutionary drug that can prevent blindness in premature babies.
Ranibizumab will now be offered as...
Defence Therapeutics details impressive Accum™ patent portfolio
Leading biotechnology company Defence Therapeutics explores its growing patent portfolio for the company’s flagship AccumTM-based platform.
Defence Therapeutics is harnessing the power of AccumTM to...
Revolutionising the NHS: UK Government injects £21m for AI healthcare technology
The UK Government has announced it will fund £21m to roll out AI healthcare technology across the NHS.
Announced today by the Health and Social...
Pulsar Helium: Unmatched high-grade helium supply for the medical industry
With the helium shortage affecting MRI and respiratory gases, Pulsar Helium’s high-grade asset provides hope for the medical industry's helium supply.
Last year the American...
Defence’s Accum™ technology effectiveness shown in published patent application
Defence Therapeutics has announced the publication of its new international (PCT) patent application. This demonstrates the effectiveness of Defence’s Accum™-based technology to intracellularly deliver...
Cordyceps and CBD oil: A revolutionary partnership in health and wellness
In the contemporary era of health consciousness, holistic wellness, and the pursuit of natural remedies, two significant players have emerged: Cordyceps and CBD oil.
Cordyceps...
Defence Therapeutics has reached the final stages of AccuTOXTM for its phase I clinical...
Defence Therapeutics has announced that it has reached the final stages of its AccuTOXTM Chemistry, Manufacturing, and Controls (CMC).
A Canadian biopharmaceutical company specialised in...
